First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
Horn, Leora, Mansfield, Aaron S, Szczęsna, Aleksandra, Havel, Libor, Krzakowski, Maciej, Hochmair, Maximilian J, Huemer, Florian, Losonczy, György, Johnson, Melissa L, Nishio, Makoto, Reck, Martin, Mok, Tony, Lam, Sivuonthanh, Shames, David S, Liu, Juan, Ding, Beiying, Lopez-Chavez, Ariel, Kabbinavar, Fairooz, Lin, Wei, Sandler, Alan, Liu, Stephen V
Published in The New England journal of medicine (06.12.2018)
Published in The New England journal of medicine (06.12.2018)
Get full text
Journal Article
Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
SPIGEL, David R, ERVIN, Thomas J, GOVINDAN, Ramaswamy, PATEL, Taral, ORLOV, Sergey V, WERTHEIM, Michael S, WEI YU, JIPING ZHA, YAUCH, Robert L, PATEL, Premal H, PHAN, See-Chun, PETERSON, Amy C, RAMLAU, Rodryg A, DANIEL, Davey B, GOLDSCHMIDT, Jerome H, BLUMENSCHEIN, George R, KRZAKOWSKI, Maciej J, ROBINET, Gilles, GODBERT, Benoit, BARLESI, Fabrice
Published in Journal of clinical oncology (10.11.2013)
Published in Journal of clinical oncology (10.11.2013)
Get full text
Journal Article
Conference Proceeding
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
Reck, Martin, Dr, Kaiser, Rolf, MD, Mellemgaard, Anders, MD, Douillard, Jean-Yves, Prof, Orlov, Sergey, Prof, Krzakowski, Maciej, Prof, von Pawel, Joachim, MD, Gottfried, Maya, MD, Bondarenko, Igor, Prof, Liao, Meilin, Prof, Gann, Claudia-Nanette, MD, Barrueco, José, PhD, Gaschler-Markefski, Birgit, PhD, Novello, Silvia, Prof
Published in The lancet oncology (01.02.2014)
Published in The lancet oncology (01.02.2014)
Get full text
Journal Article
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial
Butts, Charles, Dr, Socinski, Mark A, Prof, Mitchell, Paul L, MD, Thatcher, Nick, Prof, Havel, Libor, MD, Krzakowski, Maciej, Prof, Nawrocki, Sergiusz, MD, Ciuleanu, Tudor-Eliade, MD, Bosquée, Lionel, MD, Trigo, José Manuel, MD, Spira, Alexander, MD, Tremblay, Lise, MD, Nyman, Jan, MD, Ramlau, Rodryg, MD, Wickart-Johansson, Gun, MD, Ellis, Peter, MD, Gladkov, Oleg, MD, Pereira, José Rodrigues, MD, Eberhardt, Wilfried Ernst Erich, MD, Helwig, Christoph, Dipl Stat, Schröder, Andreas, MD, Shepherd, Frances A, Prof
Published in The lancet oncology (2014)
Published in The lancet oncology (2014)
Get full text
Journal Article
Web Resource
EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study
Pirker, Robert, Prof, Pereira, Jose R, MD, von Pawel, Joachim, MD, Krzakowski, Maciej, Prof, Ramlau, Rodryg, MD, Park, Keunchil, Prof, de Marinis, Filippo, MD, Eberhardt, Wilfried EE, MD, Paz-Ares, Luis, MD, Störkel, Stephan, Prof, Schumacher, Karl-Maria, MD, von Heydebreck, Anja, PhD, Celik, Ilhan, Prof, O'Byrne, Kenneth J, Prof
Published in The lancet oncology (2012)
Published in The lancet oncology (2012)
Get full text
Journal Article
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study
Ciuleanu, Tudor, MD, Brodowicz, Thomas, MD, Zielinski, Christoph, Prof, Kim, Joo Hang, MD, Krzakowski, Maciej, Prof, Laack, Eckart, MD, Wu, Yi-Long, Prof, Bover, Isabel, MD, Begbie, Stephen, MD, Tzekova, Valentina, MD, Cucevic, Branka, MD, Pereira, Jose Rodrigues, MD, Yang, Sung Hyun, MD, Madhavan, Jayaprakash, MD, Sugarman, Katherine P, MD, Peterson, Patrick, PhD, John, William J, MD, Krejcy, Kurt, MD, Belani, Chandra P, Dr
Published in The Lancet (British edition) (24.10.2009)
Published in The Lancet (British edition) (24.10.2009)
Get full text
Journal Article
Randomized Phase II Study of Dacomitinib (PF-00299804), an Irreversible Pan–Human Epidermal Growth Factor Receptor Inhibitor, Versus Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
RAMALINGAM, Suresh S, BLACKHALL, Fiona, LETRENT, Stephen P, RUIZ-GARCIA, Ana, TAYLOR, Ian, LIANG, Jane Q, CAMPBELL, Alicyn K, O'CONNELL, Joseph, BOYER, Michael, KRZAKOWSKI, Maciej, BARRIOS, Carlos H, PARK, Keunchil, BOVER, Isabel, DAE SEOG HEO, ROSELL, Rafael, TALBOT, Denis C, FRANK, Richard
Published in Journal of clinical oncology (20.09.2012)
Published in Journal of clinical oncology (20.09.2012)
Get full text
Journal Article
Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non–Small-Cell Lung Cancer
SCAGLIOTTI, Giorgio, NOVELLO, Silvia, AREN, Osvaldo, CSOLLAK, Maria, ALBERT, Istvan, BARRIOS, Carlos Henrique, GROSSI, Francesco, KIZAKOWSKI, Maciej, CUPIT, Lisa, CIHON, Frank, DIMATTEO, Sandra, HANNA, Nasser, VON PAWEL, Joachim, RECK, Martin, RODRIGUES PEREIRA, José, THOMAS, Michael, ABRAO MIZIARA, José Elias, BALINT, Beatrix, DE MARINIS, Filippo, KELLER, Alan
Published in Journal of clinical oncology (10.04.2010)
Published in Journal of clinical oncology (10.04.2010)
Get full text
Journal Article
Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial
SCAGLIOTTI, Giorgio V, KRZAKOWSKI, Maciej, PAPAI, Zsolt S, KARASEVA, Nina, THONGPRASERT, Sumitra, DALMAU PORTULAS, Elsa, PAWEL, Joachim Von, KE ZHANG, SELARU, Paulina, TYE, Lesley, CHAO, Richard C, GOVINDAN, Ramaswamy, SZCZESNA, Aleksandra, STRAUSZ, Janos, MAKHSON, Anatoly, RECK, Martin, WIERZBICKI, Rafal F, ALBERT, Istvan, THOMAS, Michael, ABRAO MIZIARA, Jose Elias
Published in Journal of clinical oncology (10.06.2012)
Published in Journal of clinical oncology (10.06.2012)
Get full text
Journal Article
Cardiovascular Complications of Systemic Therapy in Non-Small-Cell Lung Cancer
Zaborowska-Szmit, Magdalena, Krzakowski, Maciej, Kowalski, Dariusz M, Szmit, Sebastian
Published in Journal of clinical medicine (27.04.2020)
Published in Journal of clinical medicine (27.04.2020)
Get full text
Journal Article
Treatment outcomes of patients with primary tracheal tumors - analysis of a large retrospective series
Piórek, Aleksandra, Płużański, Adam, Knetki-Wróblewska, Magdalena, Winiarczyk, Kinga, Tabor, Sylwia, Teterycz, Paweł, Kowalski, Dariusz M, Krzakowski, Maciej
Published in BMC cancer (05.06.2024)
Published in BMC cancer (05.06.2024)
Get full text
Journal Article
Immune checkpoint inhibitors combined with tyrosine kinase inhibitors or immunotherapy for treatment-naïve metastatic clear-cell renal cell carcinoma-A network meta-analysis. Focus on cabozantinib combined with nivolumab
Niewada, Maciej, Macioch, Tomasz, Konarska, Magdalena, Mela, Aneta, Goszczyński, Adam, Przekopińska, Bogusława, Rajkiewicz, Karolina, Wysocki, Piotr, Krzakowski, Maciej
Published in Frontiers in pharmacology (03.03.2023)
Published in Frontiers in pharmacology (03.03.2023)
Get full text
Journal Article
Erlotinib in Advanced Non-small Cell Lung Cancer: Efficacy and Safety Findings of the Global Phase IV Tarceva Lung Cancer Survival Treatment Study
Reck, Martin, van Zandwijk, Nico, Gridelli, Cesare, Baliko, Zoltan, Rischin, Danny, Allan, Simon, Krzakowski, Maciej, Heigener, David
Published in Journal of thoracic oncology (01.10.2010)
Published in Journal of thoracic oncology (01.10.2010)
Get full text
Journal Article
Efficacy of Immunotherapy in Second-Line Treatment of KRAS -Mutated Patients with Non-Small-Cell Lung Cancer-Data from Daily Practice
Knetki-Wróblewska, Magdalena, Tabor, Sylwia, Płużański, Adam, Lewandowska, Zofia, Tysarowski, Andrzej, Pawlik, Hubert, Kowalski, Dariusz M, Krzakowski, Maciej
Published in Current oncology (Toronto) (29.12.2022)
Published in Current oncology (Toronto) (29.12.2022)
Get full text
Journal Article
Pembrolizumab monotherapy survival benefits in metastatic non-small-cell lung cancer: a systematic review of real-world data
Macioch, Tomasz, Krzakowski, Maciej, Gołębiewska, Klaudia, Dobek, Małgorzata, Warchałowska, Natalia, Niewada, Maciej
Published in Discover. Oncology (24.07.2024)
Published in Discover. Oncology (24.07.2024)
Get full text
Journal Article
Performance-Status Deterioration during Sequential Chemo-Radiotherapy as a Predictive Factor in Locally Advanced Non-Small Cell Lung Cancer
Olszyna-Serementa, Marta, Zaborowska-Szmit, Magdalena, Szmit, Sebastian, Jaśkiewicz, Piotr, Zajda, Katarzyna, Krzakowski, Maciej, Kowalski, Dariusz M
Published in Current oncology (Toronto) (07.02.2023)
Published in Current oncology (Toronto) (07.02.2023)
Get full text
Journal Article
Clinicopathological characteristics of patients with primary tracheal tumors: Analysis of eighty‐nine cases
Piórek, Aleksandra, Płużański, Adam, Teterycz, Paweł, Tabor, Sylwia, Winiarczyk, Kinga, Knetki‐Wróblewska, Magdalena, Kowalski, Dariusz M., Krzakowski, Maciej
Published in Thoracic cancer (01.04.2024)
Published in Thoracic cancer (01.04.2024)
Get full text
Journal Article
Cyclophosphamide and tucotuzumab (huKS-IL2) following first-line chemotherapy in responding patients with extensive-disease small-cell lung cancer
Gladkov, Oleg, Ramlau, Rodryg, Serwatowski, Piotr, Milanowski, Janusz, Tomeczko, Janusz, Komarnitsky, Philip B, Kramer, Daniel, Krzakowski, Maciej J
Published in Anti-cancer drugs (01.11.2015)
Published in Anti-cancer drugs (01.11.2015)
Get more information
Journal Article
Thymic epithelial tumors: Do we know all the prognostic factors?
Knetki‐Wróblewska, Magdalena, Kowalski, Dariusz M., Olszyna‐Serementa, Marta, Krzakowski, Maciej, Szołkowska, Małgorzata
Published in Thoracic cancer (01.02.2021)
Published in Thoracic cancer (01.02.2021)
Get full text
Journal Article